Review
Open access
Sep 2026
mRNA Vaccines as Novel Immunotherapeutic Approaches in Gastrointestinal Cancers
Messenger RNA vaccines have moved rapidly from the infectious-disease area into oncology. They now represent an attractive therapeutic option for gastrointestinal (GI) cancers. Personalised constructs, designed to elicit tumour-specific T-cell immunity, have shown acceptable safety and clear immunogenicity in early-pha...
M. Ghidini, Federica Novazzi, N. Denaro et al.
· Cells · 0 citations